These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9027662)

  • 21. Drug-induced vanishing bile duct syndrome: response to ursodiol.
    O'Brien CB; Shields DS; Saul SH; Reddy KR
    Am J Gastroenterol; 1996 Jul; 91(7):1456-7. PubMed ID: 8678017
    [No Abstract]   [Full Text] [Related]  

  • 22. Obstetric cholestasis characterized by extremely elevated serum transaminases.
    Karamouti M; Gerovasilis F; Georgadakis G
    Int J Gynaecol Obstet; 2007 Aug; 98(2):157-8. PubMed ID: 17588573
    [No Abstract]   [Full Text] [Related]  

  • 23. Ursodeoxycholic acid for treatment of cholestasis in patients with hepatic amyloidosis.
    Faust D; Akoglu B; Ristic G; Milovic V
    Vojnosanit Pregl; 2009 Jun; 66(6):482-6. PubMed ID: 19583148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure.
    De Marco G; Sordino D; Bruzzese E; Di Caro S; Mambretti D; Tramontano A; Colombo C; Simoni P; Guarino A
    Aliment Pharmacol Ther; 2006 Jul; 24(2):387-94. PubMed ID: 16842466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intrahepatic cholestasis of pregnancy. New treatment].
    Ranek L; Ott P
    Ugeskr Laeger; 1999 Sep; 161(39):5411-2. PubMed ID: 10553352
    [No Abstract]   [Full Text] [Related]  

  • 27. Ursodeoxycholic acid therapy in children with cholestatic liver disease.
    Dinler G; Koçak N; Yüce A; Gürakan F; Ozen H
    Turk J Pediatr; 1999; 41(1):91-8. PubMed ID: 10770681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. URSO in obstetric cholestasis: not a bear market.
    Elias E
    Gut; 1999 Sep; 45(3):331-2. PubMed ID: 10446097
    [No Abstract]   [Full Text] [Related]  

  • 29. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts].
    Brites D; Rodrigues CM
    J Hepatol; 1998 Nov; 29(5):743-51. PubMed ID: 9833912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
    Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
    Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does ursodeoxycholic acid exert a protective effect on liver grafts in orthotopic liver transplantation?
    Herzer K; Fingas CD; Canbay A
    Digestion; 2012; 86(3):206-7. PubMed ID: 22948005
    [No Abstract]   [Full Text] [Related]  

  • 32. [Intrahepatic cholestasis of pregnancy treated with ursodeoxycholic acid. Results from a two-year survey at Rigshospitalet, Skejby Hospital and Odense University Hospital].
    Jochumsen KM; Svane D; Bødker B; Skajaa K; Westergaard JG
    Ugeskr Laeger; 2003 Sep; 165(40):3825-8. PubMed ID: 14560505
    [No Abstract]   [Full Text] [Related]  

  • 33. Ursodeoxycholic acid therapy in pregnant women with cholestasis.
    Diaferia A; Nicastri PL; Tartagni M; Loizzi P; Iacovizzi C; Di Leo A
    Int J Gynaecol Obstet; 1996 Feb; 52(2):133-40. PubMed ID: 8855091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrahepatic Cholestasis Owing to a Novel Heterozygous ABCG8 Mutation and SLC4A2 Polymorphism With Favorable Outcome Under Ursodeoxycholic Acid.
    Ciocan D; Voican CS; Barbu V; Corpechot C; Rainteau D; Prevot S; Lebrun A; Perlemuter G
    Am J Gastroenterol; 2019 Sep; 114(9):1556-1559. PubMed ID: 31335361
    [No Abstract]   [Full Text] [Related]  

  • 35. [Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid].
    Mörk H; al-Taie O; Klinge O; Scheurlen M
    Z Gastroenterol; 1997 Dec; 35(12):1087-91. PubMed ID: 9487641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 37. Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis.
    Gurung V; Williamson C; Chappell L; Chambers J; Briley A; Broughton Pipkin F; Thornton J
    BMC Pregnancy Childbirth; 2009 May; 9():19. PubMed ID: 19445704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
    Brites D; Rodrigues CM; Oliveira N; Cardoso M; Graça LM
    J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is ursodeoxycholic acid effective for intrahepatic cholestasis of pregnancy?
    Sepúlveda Marín S; Contreras Maragaño V; Vera C
    Medwave; 2016 Jan; 16 Suppl 1():e6361. PubMed ID: 26817509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correction of metabolic disturbances in patients with cholestasis].
    Rodonezhskaia EV; Kharchenko NV
    Lik Sprava; 2001; (3):148-9. PubMed ID: 11560006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.